34 / 88
34
Scientific Programme /
Monday, 19 June 2017
WFSBP 2017
MON
013
Effective antidepressant treatment with alternating
intravenous racemic ketamine and electroconvulsive
therapy in treatment resistant depression: A case report
Lucie Bartova, Austria
A. Weidenauer, M. Dold, A. Naderi-Heiden, S. Kasper,
M. Willeit, N. Praschak-Rieder
014
The use of psychopharmacological augmentations
and combination strategies in depressive patients treat-
ed in tertiary psychiatric centers: A systematic evalua-
tion among 8 European countries
Markus Dold, Austria
A. Kautzky, L. Bartova, U. Rabl, D. Souery, J. Mendlewicz,
A. Serretti, S. Porcelli, J. Zohar, S. Montgomery, S. Kasper
015
The efficacy, safety and tolerability of probiotics
on depressive symptoms: Pilot study results
Caroline Wallace, Canada
J. Foster, S. Kennedy, R. Milev
016
A systematic review of the clinimetric properties
of the 6-item version of the Hamilton Depression Rating
Scale (HAM-D6)
Nina Timmerby, Denmark
J. Husted Andersen, S. Søndergaard, S. Dinesen
Østergaard, P. Bech
017
Relationship between rapheal hypoechogenicity
and personality as possible markers of a disposition to
develop depressive and anxiety disorders
Petr Silhán, Czech Republic
L. Hosák, M. Hýža, D. Pernicková, J. Vantuch,
M. Jelínková, D. Skoloudík
019
Aerobic exercise as add-on treatment in depressed
inpatients improves cognitive domains but has no addi-
tional effect on emotional symptoms
Christian Imboden, Switzerland
M. Gerber, J. Beck, U. Pühse, M. Hatzinger, E. Holsboer-
Trachsler
020
Cognitive complaints and predictors of perceived
cognitive dysfunction in adults with major depressive
disorder: Findings from the Cognitive Dysfunction in
Asians with Depression (CogDAD) study
Manit Srisurapanont, Thailand
Y. K. Yang, N. Z. Zainal, S. Jambunathan, Y. M. Mok,
H.-N. Chan, C. D., Della, N. Amir, P. Kalita
021
Discrepancy between objective and subjective
cognition in adults with major depressive disorders
Manit Srisurapanont, Thailand
S. Suttajit, K. Eurviriyanukul, P. Varnado
022
Increased blood BDNF in healthy individuals with
a family history of depression
Ulla Knorr, Denmark
M. Greisen Søndergaard, P. Koefoed, A. Jørgensen,
M. Fauerholt-Jepsen, M. Vinberg, L. Kessing
023
Interaction of genetic risk and early life stress on
risk of depression investigated in a nationwide, Danish
case-cohort study
Nis Palm Suppli, Denmark
E. Agerbo, K. K. Andersen, V. Manikandan, M. E. Benros,
W. Thompson, T. Munk-Olsen, M. Nordentoft,
P. B. Mortensen, K. L. Musliner
SA-01 INDUSTRY SPONSORED SATELLITE SYMPOSIUM
13:15–14:45
Auditorium 12
Sunovion Satellite Symposium
Please see page 78
T24: NEUROPATHOLOGY
TFS-02
WFSBP TASK FORCE SYMPOSIUM
15:00–16:30
Congress Hall A 3
Post-mortem findings across psychiatric disorders and
their association with cognitive symptoms
Chair:
Andrea Schmitt, Germany
Co-Chair: Johann Steiner, Germany
001
Alterations in hippocampal oligodendrocyte and
neuron number in patients with schizophrenia, Bipolar
Disorder (BP) and major depression
Peter Falkai, Germany
002
GABAergic system impairment in the hippocam-
pus and superior temporal gyrus of patients with para-
noid schizophrenia
Johann Steiner, Germany
003
Presynaptic contributions to cognitive reserve
William Honer, Canada
004
Different changes in cortical muscarinic receptors
in psychiatric and neurological disorders
Andrew Gibbons, Australia